Skip to main content

The anti-inflammatory effects of atorvastatin upon the outcome of traumatic brain injury patients: A randomized-controlled double-blind clinical trial

Research Authors
Emad Zarief Kamel, Nagwa M Ibrahem, Hazem Abu Zeid Yousef, Mohammed Gaber Farghly, Shady Safwat Hassan, Khaled Tolba Younes, Yasser Ashraf Gamal, Mina Maher Raouf, Omar Makram Soliman
Research Date
Research Journal
Egyptian Journal of Anaesthesia
Research Publisher
Egyptian Journal of Anaesthesia
Research Year
2023
Research Abstract

Traumatic brain injury (TBI) is a quite common health problem. A lot of delayed complications are related to inflammatory responses that occurred within the brain itself. Atorvastatin is related to lipid lowering drugs carrying some anti-inflammatory properties and upon this fact this study hypothesis was built.

Methods

Twenty adult patients with TBI, Glasgow coma scale (GCS) 9–11. Patients were equally and randomly allocated into two groups (group C as control group and group S received atorvastatin 40 mg once daily for 48 h). After 48 h, participants have undergone magnetic resonance imaging brain spectroscopy examination (MRS). The spectral peaks of N-Acetyl aspartate (NAA), Choline, and Creatinine (Cr) were assessed in brain tissue. The primary outcome was presented as ratios of NAA/Cr), Cho/Cr, and NAA/Cho. Other outcomes included GCS and ICU stay